- Product Details
Keywords
- 1000413-72-8
- TAK875
- 98%
Quick Details
- ProName: 1000413-72-8 TAK875
- CasNo: 1000413-72-8
- Molecular Formula: C29H32O7S
- Appearance: Powder
- Application: Pharma intermediates
- DeliveryTime: 7 days
- PackAge: 1KG -200KG Drum with pallet
- Port: Shanghai port
- ProductionCapacity: 30 Metric Ton/Month
- Purity: 98.0%Min
- Storage: Room temperature
- Transportation: by sea or by air or by courier
- LimitNum: 1 Kilogram
Superiority
Our company was built in 2009 with an ISO certificate.In the past 5 years, we have grown up as a famous fine chemicals supplier in China and we had established stable business relationships with Samsung,LG,Merck,Thermo Fisher Scientific and so on.
Our main business covers the fields below:
1.Noble Metal Catalysts (Pt.Pd...)
2.Organic Phosphine Ligands (Tert-butyl-phosphine.Cyclohexyl-phosphine...)
3.OLED intermediates (Fluorene,Carbazole,Boric acid...)
4.Customs Synthesis
Our advantage:
1.Higest quality and good package
2.Fast delivery
3.Better payment term
4.Fast response to customer within 6 hours
5.Good business credit in Europe ,US ,Japan ,Korea
Details
TAK875 Basic information |
Product Name: | TAK875 |
Synonyms: | TAK875;3-Benzofuranacetic acid, 6-[[2',6'-diMethyl-4'-[3-(Methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]Methoxy]-2,3-dihydro-, (3S)-;(3S)-6-[[2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]methoxy]-2,3-dihydro-3-benzofuranacetic acid;TAK-875,TAK875;[(3S)-6-({2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy]-3-biphenylyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid;(S)-2-(6-((2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy)-2,3-dihydrobenzofuran-3-yl)acetic acid;TAK-875, >=98%;Fasiglifam |
CAS: | 1000413-72-8 |
MF: | C29H32O7S |
MW: | 524.62518 |
EINECS: | -0 |
Product Categories: | Inhibitors |
Mol File: | 1000413-72-8.mol |
|
TAK875 Chemical Properties |
density | 1.252 |
Safety Information |
TAK875 Usage And Synthesis |
Uses | TAK-876 is a selective G protein-coupled receptor 40 (GPR40) agonist. TAK-876 is a novel oral medication that has been developed to improve the secretion of insulin in a glucose-dependent manner, whic h has the potential to improve the control of blood sugar levels without the risk of hypoglycemia. |
TAK875 Preparation Products And Raw materials |